ARTICLE | Company News
Vanda, Taro Pharmaceutical deal
October 31, 2016 7:00 AM UTC
Vanda granted Taro non-exclusive, U.S. rights to manufacture and commercialize a generic version of Vanda’s Fanapt iloperidone, effective November 2027. The license settled patent litigation against T...